MARATTO

preprint

Enhancing Maternal and Infant Health: Insights from Comprehensive PMTCT OF HIV Services in Rwanda

2024Open accessMakerere University

Abstract

<title>Abstract</title> Background Despite the remarkable achievements in preventing and controlling HIV-1 at global level, Mother-to-Child Transmission (MTCT) of HIV and the associated mortality continue to be unacceptably high. This remains a significant public health concern, with efforts focused on increasing the global coverage of Prevention of Mother-to-Child Transmission (PMTCT) of HIV programs. Methods This study expounds on the multifaceted dimensions of PMTCT interventions and their impact on maternal and child health outcomes in Rwanda, using a qualitative approach with pregnant mothers living with HIV navigating PMTCT clinics for 18 months. Results The results indicate that PMTCT services play a crucial role in enhancing the health and well-being of both pregnant mothers living with HIV and their infants. The primary reinforcements established include; nutritional support, continuous follow-up and postnatal care, education on HIV transmission, and access to government-provided medical insurance. Conclusions Based on the results, interventions for PMTCT services are compelling on economic and social grounds in many resource-limited settings in Rwanda and should remain at the forefront of global HIV prevention efforts.

Research topics

  • Global Maternal and Child Health
  • HIV/AIDS Research and Interventions
  • Child Nutrition and Water Access

Read the original research

This page summarises published work. The authoritative version sits with the publisher.

DOI: 10.21203/rs.3.rs-5316782/v1

Is something wrong with this record? Report it or request removal.

Discussion

Discuss this research

Have you built on this work, tried to replicate it, or seen it applied in practice? Share what you know. Verified researchers and MARATTO™ domain experts can open a discussion, and any member can reply. Contributions are reviewed before they appear.

No discussion yet. Open the first thread.